Skip to main content
Clinical Trials/NCT01122277
NCT01122277
Unknown
Not Applicable

Klinisches Register RaFTinG - Rational Fluid Therapy in Germany

Ludwig-Maximilians - University of Munich2 sites in 1 country4,000 target enrollmentMay 2010
ConditionsPatients in ICU

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patients in ICU
Sponsor
Ludwig-Maximilians - University of Munich
Enrollment
4000
Locations
2
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this observational study is the prospective documentation and evaluation of the status quo of volume therapy in German intensive care units.

Detailed Description

The purpose of RaFTinG is the prospective documentation and evaluation of the demographic, diagnostic and therapeutic characteristics of unselected patients and their treatment in intensive care units (ICU) in Germany. Documentation will not only include their stay in the ICU but a follow up query 90 days after discharge from the ICU.

Registry
clinicaltrials.gov
Start Date
May 2010
End Date
October 2011
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ICU patients with an indication for fluid/volume therapy

Exclusion Criteria

  • Patients hospitalized by order of a court of law or a government agency

Outcomes

Primary Outcomes

Not specified

Study Sites (2)

Loading locations...

Similar Trials